Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment

Overview of attention for article published in Frontiers in Chemistry, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 8 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,556 followers.

RT @FrontChemistry: New Research: Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment:…

31 Jan 2024

Reply Repost Favourite

New Research: Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment: Glioblastoma multiforme (GBM) is a highly aggressive malignant primary tumor in the central nervous system. Despite… https://t.co/frNBpRX

08 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.